Lisa G Rider

Summary

Affiliation: National Institutes of Health
Country: USA

Publications

  1. ncbi request reprint Neopterin and quinolinic acid are surrogate measures of disease activity in the juvenile idiopathic inflammatory myopathies
    Lisa G Rider
    Laboratory of Molecular and Developmental Immunology, Division of Monoclonal Antibodies, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, MD 20892, USA
    Clin Chem 48:1681-8. 2002
  2. ncbi request reprint Outcome assessment in the adult and juvenile idiopathic inflammatory myopathies
    Lisa G Rider
    National Institute of Environmental Health Sciences, NIH 9 Memorial Drive, Room 1W107, MSC 0958 Bethesda, MD 20892, USA
    Rheum Dis Clin North Am 28:935-77. 2002
  3. ncbi request reprint Defining Clinical Improvement in Adult and Juvenile Myositis
    Lisa G Rider
    Enviromental Autoimmunity Group, National Institute of Enviromental Health Sciences, National Institutes of Health, Bethesda, MD 20892, USA
    J Rheumatol 30:603-17. 2003
  4. ncbi request reprint International consensus on preliminary definitions of improvement in adult and juvenile myositis
    Lisa G Rider
    National Institute of Environmental Health Sciences, NIH, Bethesda, Maryland 20892, USA
    Arthritis Rheum 50:2281-90. 2004
  5. ncbi request reprint Immunogenetic risk and protective factors for the idiopathic inflammatory myopathies: distinct HLA-A, -B, -Cw, -DRB1, and -DQA1 allelic profiles distinguish European American patients with different myositis autoantibodies
    Terrance P O'Hanlon
    National Institute of Environmental Health Sciences, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland 20892, USA
    Medicine (Baltimore) 85:111-27. 2006
  6. ncbi request reprint HLA polymorphisms in African Americans with idiopathic inflammatory myopathy: allelic profiles distinguish patients with different clinical phenotypes and myositis autoantibodies
    Terrance P O'Hanlon
    National Institute of Environmental Health Sciences, Bethesda, Maryland 20892, USA
    Arthritis Rheum 54:3670-81. 2006
  7. pmc Immunogenetic risk and protective factors for juvenile dermatomyositis in Caucasians
    Gulnara Mamyrova
    National Institute of Environmental Health Sciences, NIH, Bethesda, Maryland 20892, USA
    Arthritis Rheum 54:3979-87. 2006
  8. pmc Immunoglobulin gene polymorphisms are susceptibility factors in clinical and autoantibody subgroups of the idiopathic inflammatory myopathies
    Terrance P O'Hanlon
    National Institute of Environmental Health Sciences, NIH, Bethesda, Maryland 20892, USA
    Arthritis Rheum 58:3239-46. 2008
  9. pmc Cytokine gene polymorphisms as risk and severity factors for juvenile dermatomyositis
    Gulnara Mamyrova
    National Institute of Environmental Health Sciences, NIH, Bethesda, Maryland 20892 1301, USA
    Arthritis Rheum 58:3941-50. 2008
  10. pmc Validation of manual muscle testing and a subset of eight muscles for adult and juvenile idiopathic inflammatory myopathies
    Lisa G Rider
    Environmental Autoimmunity Group, Office of Clinical Research, National Institute of Environmental Health Sciences NIH, 10 Center Drive, Bethesda, MD 20892 1301, USA
    Arthritis Care Res (Hoboken) 62:465-72. 2010

Detail Information

Publications44

  1. ncbi request reprint Neopterin and quinolinic acid are surrogate measures of disease activity in the juvenile idiopathic inflammatory myopathies
    Lisa G Rider
    Laboratory of Molecular and Developmental Immunology, Division of Monoclonal Antibodies, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, MD 20892, USA
    Clin Chem 48:1681-8. 2002
    ..We evaluated the utility of neopterin and quinolinic acid (QUIN) as surrogate measures of disease activity in juvenile idiopathic inflammatory myopathies (IIMs)...
  2. ncbi request reprint Outcome assessment in the adult and juvenile idiopathic inflammatory myopathies
    Lisa G Rider
    National Institute of Environmental Health Sciences, NIH 9 Memorial Drive, Room 1W107, MSC 0958 Bethesda, MD 20892, USA
    Rheum Dis Clin North Am 28:935-77. 2002
    ..Improved clinical care and more rapid development of new therapies for patients with myositis will be the ultimate gains realized from these efforts...
  3. ncbi request reprint Defining Clinical Improvement in Adult and Juvenile Myositis
    Lisa G Rider
    Enviromental Autoimmunity Group, National Institute of Enviromental Health Sciences, National Institutes of Health, Bethesda, MD 20892, USA
    J Rheumatol 30:603-17. 2003
    ..This workshop is the first of several planned to develop multidisciplinary, international consensus on the conduct and reporting of IIM clinical trials...
  4. ncbi request reprint International consensus on preliminary definitions of improvement in adult and juvenile myositis
    Lisa G Rider
    National Institute of Environmental Health Sciences, NIH, Bethesda, Maryland 20892, USA
    Arthritis Rheum 50:2281-90. 2004
    ..To use a core set of outcome measures to develop preliminary definitions of improvement for adult and juvenile myositis as composite end points for therapeutic trials...
  5. ncbi request reprint Immunogenetic risk and protective factors for the idiopathic inflammatory myopathies: distinct HLA-A, -B, -Cw, -DRB1, and -DQA1 allelic profiles distinguish European American patients with different myositis autoantibodies
    Terrance P O'Hanlon
    National Institute of Environmental Health Sciences, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland 20892, USA
    Medicine (Baltimore) 85:111-27. 2006
    ....
  6. ncbi request reprint HLA polymorphisms in African Americans with idiopathic inflammatory myopathy: allelic profiles distinguish patients with different clinical phenotypes and myositis autoantibodies
    Terrance P O'Hanlon
    National Institute of Environmental Health Sciences, Bethesda, Maryland 20892, USA
    Arthritis Rheum 54:3670-81. 2006
    ..To investigate possible associations of HLA polymorphisms with idiopathic inflammatory myopathy (IIM) in African Americans, and to compare this with HLA associations in European American IIM patients with IIM...
  7. pmc Immunogenetic risk and protective factors for juvenile dermatomyositis in Caucasians
    Gulnara Mamyrova
    National Institute of Environmental Health Sciences, NIH, Bethesda, Maryland 20892, USA
    Arthritis Rheum 54:3979-87. 2006
    ....
  8. pmc Immunoglobulin gene polymorphisms are susceptibility factors in clinical and autoantibody subgroups of the idiopathic inflammatory myopathies
    Terrance P O'Hanlon
    National Institute of Environmental Health Sciences, NIH, Bethesda, Maryland 20892, USA
    Arthritis Rheum 58:3239-46. 2008
    ..To investigate possible associations of GM and KM markers with adult and juvenile forms of the idiopathic inflammatory myopathies (IIMs) in Caucasian and African American patients...
  9. pmc Cytokine gene polymorphisms as risk and severity factors for juvenile dermatomyositis
    Gulnara Mamyrova
    National Institute of Environmental Health Sciences, NIH, Bethesda, Maryland 20892 1301, USA
    Arthritis Rheum 58:3941-50. 2008
    ....
  10. pmc Validation of manual muscle testing and a subset of eight muscles for adult and juvenile idiopathic inflammatory myopathies
    Lisa G Rider
    Environmental Autoimmunity Group, Office of Clinical Research, National Institute of Environmental Health Sciences NIH, 10 Center Drive, Bethesda, MD 20892 1301, USA
    Arthritis Care Res (Hoboken) 62:465-72. 2010
    ..To validate manual muscle testing (MMT) for strength assessment in juvenile and adult dermatomyositis (DM) and polymyositis (PM)...
  11. pmc Damage extent and predictors in adult and juvenile dermatomyositis and polymyositis as determined with the myositis damage index
    Lisa G Rider
    Environmental Autoimmunity Group, National Institute of Environmental Health Sciences, NIH, Bethesda, MD 20892 1301, USA
    Arthritis Rheum 60:3425-35. 2009
    ..We undertook this study to validate the Myositis Damage Index (MDI) in juvenile and adult myositis, to describe the degree and types of damage and to develop predictors of damage...
  12. pmc Predictors of acquired lipodystrophy in juvenile-onset dermatomyositis and a gradient of severity
    April Bingham
    From Office of Clinical Research, National Institute of Environmental Health Sciences, National Institutes of Health, Bethesda, Maryland 20892 1301, USA
    Medicine (Baltimore) 87:70-86. 2008
    ..Further study is warranted to investigate the pathogenesis of acquired LD in patients with DM...
  13. doi request reprint The clinical phenotypes of the juvenile idiopathic inflammatory myopathies
    Mona Shah
    Environmental Autoimmunity Group, Program of Clinical Research, National Institute of Environmental Health Sciences, National Institutes of Health, DHHS, Bethesda, Maryland 20892 1301, USA
    Medicine (Baltimore) 92:25-41. 2013
    ..We conclude that juvenile myositis is a heterogeneous group of illnesses with distinct clinical subgroups, defined by varying clinical and demographic characteristics, laboratory features, and outcomes...
  14. pmc Environmental factors preceding illness onset differ in phenotypes of the juvenile idiopathic inflammatory myopathies
    Lisa G Rider
    Environmental Autoimmunity Group, National Institute of Environmental Sciences, National Institutes of Health, DHHS, Clinical Research Center Room 4 2352, 10 Center Drive, MSC 1301, Bethesda, MD 20892 1301, USA
    Rheumatology (Oxford) 49:2381-90. 2010
    ..To assess whether certain environmental factors temporally associated with the onset of juvenile idiopathic inflammatory myopathies (JIIMs) differ between phenotypes...
  15. pmc Brief report: ultraviolet radiation exposure is associated with clinical and autoantibody phenotypes in juvenile myositis
    Mona Shah
    National Institute of Environmental Health Sciences, NIH, Bethesda, MD, USA
    Arthritis Rheum 65:1934-41. 2013
    ..We undertook this study to investigate the association between ultraviolet radiation (UVR) exposure and the clinical and autoantibody expression of juvenile IIM...
  16. ncbi request reprint Immunogenetic risk and protective factors for the idiopathic inflammatory myopathies: distinct HLA-A, -B, -Cw, -DRB1 and -DQA1 allelic profiles and motifs define clinicopathologic groups in caucasians
    Terrance P O'Hanlon
    National Institute of Environmental Health Sciences, Rockville, MD 20892 0958, USA
    Medicine (Baltimore) 84:338-49. 2005
    ..These variations in associated HLA polymorphisms may reflect responses to unique environmental triggers resulting in the tissue pathospecificity and distinct clinicopathologic syndromes of the IIM...
  17. pmc The heterogeneity of juvenile myositis
    Lisa G Rider
    Environmental Autoimmunity Group, National Institute of Environmental Health Sciences, Department of Health and Human Services, CRC 4 2332, MSC 1301, 10 Center Drive, Bethesda, MD 20892 1301, United States
    Autoimmun Rev 6:241-7. 2007
    ..Therapeutic trials of biologic agents, including anti-TNFalpha and anti-CD20, may aid in developing promising new therapies for these disorders...
  18. pmc Plasma proteomic profiles from disease-discordant monozygotic twins suggest that molecular pathways are shared in multiple systemic autoimmune diseases
    Terrance P O'Hanlon
    Environmental Autoimmunity Group, National Institute of Environmental Health Sciences, National Institutes of Health, DHHS, 9000 Rockville Pike, Bethesda, MD 20892, USA
    Arthritis Res Ther 13:R181. 2011
    ..We assessed plasma proteomic profiles among different SAID for evidence of common molecular pathways that could provide insights into pathogenic mechanisms shared by these diseases...
  19. pmc Metabolic abnormalities and cardiovascular risk factors in children with myositis
    Kathleen Coyle
    National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD 20892 1301, USA
    J Pediatr 155:882-7. 2009
    ..To characterize the metabolic abnormalities and risk factors for future cardiovascular disease in children with myositis...
  20. pmc Late-onset gastrointestinal pain in juvenile dermatomyositis as a manifestation of ischemic ulceration from chronic endarteropathy
    Gulnara Mamyrova
    Environmental Autoimmunity Group, National Institute of Environmental Health Sciences, Bethesda, Maryland 20892 1301, USA
    Arthritis Rheum 57:881-4. 2007
  21. pmc Gene expression profiles from discordant monozygotic twins suggest that molecular pathways are shared among multiple systemic autoimmune diseases
    Terrance P O'Hanlon
    Environmental Autoimmunity Group, National Institute of Environmental Health Sciences, National Institutes of Health, 9000 Rockville Pike, Bethesda, MD 20892, USA
    Arthritis Res Ther 13:R69. 2011
    ..The objective of this study is to determine if multiple systemic autoimmune diseases (SAID) share gene expression pathways that could provide insights into pathogenic mechanisms common to these disorders...
  22. doi request reprint Deciphering the clinical presentations, pathogenesis, and treatment of the idiopathic inflammatory myopathies
    Lisa G Rider
    Environmental Autoimmunity Group, Program of Clinical Research, National Institute of Environmental Health Sciences, National Institutes of Health, US Department of Health and Human Services, Bethesda, Maryland 20892, USA
    JAMA 305:183-90. 2011
    ..Knowledge of myositis phenotypes should enhance clinicians' ability to recognize and manage these rare disorders...
  23. ncbi request reprint Walking ability and its relationship to lower-extremity muscle strength in children with idiopathic inflammatory myopathies
    Karen Lohmann Siegel
    Rehabilitation Medicine Department, National Institutes of Health, Department of Health and Human Services, Bethesda, MD 20892, USA
    Arch Phys Med Rehabil 85:767-71. 2004
    ..To describe gait deficits and their association with lower-extremity muscle strength in children with juvenile idiopathic inflammatory myopathies (IIM)...
  24. ncbi request reprint Measuring therapeutic response in chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. Response Criteria Working Group report
    Steven Z Pavletic
    National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892 1203, USA
    Biol Blood Marrow Transplant 12:252-66. 2006
    ..The proposed response criteria are based on current expert consensus opinion and are intended to improve consistency in the conduct and reporting of chronic GVHD trials, but their use remains to be demonstrated in practice...
  25. pmc Seasonal birth patterns in myositis subgroups suggest an etiologic role of early environmental exposures
    Leora J Vegosen
    Environmental Autoimmunity Group, National Institute of Environmental Health Sciences, NIH DHHS, 10 Center Drive, Bethesda, MD 20892, USA
    Arthritis Rheum 56:2719-28. 2007
    ..To evaluate whether seasonal early environmental exposures might influence later development of autoimmune disease, by assessing distributions of birth dates in groups of patients with idiopathic inflammatory myopathies (IIMs)...
  26. ncbi request reprint Fitness as a determinant of the oxygen uptake/work rate slope in healthy children and children with inflammatory myopathy
    Bart E Drinkard
    Dept of Rehabilitation Medicine, National Institutes of Environmental Health Sciences, National Institutes of Health, 10 Center Dr, Bethesda, MD 20892 1604, USA
    Can J Appl Physiol 28:888-97. 2003
    ..We also hypothesized that delta VO2/delta would be significantly decreased in children with JDM compared to healthy children...
  27. ncbi request reprint Intra-rater and inter-rater reliability of the 10-point Manual Muscle Test (MMT) of strength in children with juvenile idiopathic inflammatory myopathies (JIIM)
    Minal Jain
    National Institutes of Health, Rehabilitation Medicine Department, Bethesda, MD 20892 1604, USA
    Phys Occup Ther Pediatr 26:5-17. 2006
    ..The purpose of this study was to determine the intra-rater and inter-rater reliability of the 0 to 10-point manual muscle testing method for children with JIIM...
  28. pmc Laboratory Test Abnormalities are Common in Polymyositis and Dermatomyositis and Differ Among Clinical and Demographic Groups
    Rita Volochayev
    Environmental Autoimmunity Group, Program of Clinical Research, National Institute of Environmental Health Sciences, National Institutes of Health, HHS, Bethesda, Maryland, USA
    Open Rheumatol J 6:54-63. 2012
    ....
  29. ncbi request reprint Differences in idiopathic inflammatory myopathy phenotypes and genotypes between Mesoamerican Mestizos and North American Caucasians: ethnogeographic influences in the genetics and clinical expression of myositis
    Ejaz A Shamim
    Center for Biologics Evaluation and Research, FDA, Bethesda, Maryland, USA
    Arthritis Rheum 46:1885-93. 2002
    ....
  30. doi request reprint Childhood socioeconomic factors and perinatal characteristics influence development of rheumatoid arthritis in adulthood
    Christine G Parks
    Epidemiology Branch, Division of Intramural Research, National Institute of Environmental Health Sciences, Durham, NC 27599, USA
    Ann Rheum Dis 72:350-6. 2013
    ..Rheumatoid arthritis (RA) has been associated with lower socioeconomic status (SES), but the reasons for this are not known...
  31. ncbi request reprint Decreased aerobic capacity in children with juvenile dermatomyositis
    Jeanne E Hicks
    Clinical Center, National Institutes of Health, Bethesda, Maryland 20892 1604, USA
    Arthritis Rheum 47:118-23. 2002
    ..To determine whether patients with juvenile dermatomyositis (DM) have limited aerobic capacity compared with healthy controls...
  32. ncbi request reprint HLA-DQA1 is not an apparent risk factor for microchimerism in patients with various autoimmune diseases and in healthy individuals
    Carol M Artlett
    Division of Rheumatology, Thomas Jefferson University, Philadelphia, Pennsylvania 19107, USA
    Arthritis Rheum 48:2567-72. 2003
    ..Furthermore, DQA1*0501 has been associated with T lymphocyte microchimerism in SSc. To better define the strength of this association, we assessed the relationship among DQA1 alleles and microchimerism...
  33. ncbi request reprint Preliminary core sets of measures for disease activity and damage assessment in juvenile systemic lupus erythematosus and juvenile dermatomyositis
    Nicolino Ruperto
    IRCCS G Gasalini, Pediatria II, Genova, Italy
    Rheumatology (Oxford) 42:1452-9. 2003
    ..To identify preliminary core sets of outcome variables for disease activity and damage assessment in juvenile systemic lupus erythematosus (JSLE) and juvenile dermatomyositis (JDM)...
  34. ncbi request reprint Validation and clinical significance of the Childhood Myositis Assessment Scale for assessment of muscle function in the juvenile idiopathic inflammatory myopathies
    Adam M Huber
    IWK Health Centre and Dalhousie University, 5850 University Avenue, Halifax, Nova Scotia B3J 3G9, Canada
    Arthritis Rheum 50:1595-603. 2004
    ....
  35. ncbi request reprint Developing international consensus on measures of improvement for patients with myositis
    Peter A Lachenbruch
    FDA Center for Biologics Evaluation and Research, USA
    Stat Methods Med Res 16:51-64. 2007
    ..We discuss criteria for determining an acceptable rule that include both numerical measures and physician acceptance...
  36. ncbi request reprint Parvovirus B19 and onset of juvenile dermatomyositis
    Gulnara Mamyrova
    JAMA 294:2170-1. 2005
  37. doi request reprint Preliminary validation and clinical meaning of the Cutaneous Assessment Tool in juvenile dermatomyositis
    Adam M Huber
    Division of Pediatric Rheumatology, IWK Health Centre and Dalhousie University, Halifax, Nova Scotia, Canada
    Arthritis Rheum 59:214-21. 2008
    ..To provide preliminary validation of the Cutaneous Assessment Tool (CAT), a new tool to assess cutaneous manifestations of juvenile dermatomyositis (DM), and to explore the clinical meaning of CAT scores...
  38. pmc Alternative scoring of the Cutaneous Assessment Tool in juvenile dermatomyositis: results using abbreviated formats
    Adam M Huber
    Izaak Walton Killam Health Centre and Dalhousie University, Halifax, Nova Scotia, Canada
    Arthritis Rheum 59:352-6. 2008
    ..The goal of this study was to determine whether alternative scoring methods would shorten the CAT without compromising its measurement characteristics...
  39. ncbi request reprint International consensus guidelines for trials of therapies in the idiopathic inflammatory myopathies
    Chester V Oddis
    University of Pittsburgh, Pittsburgh, Pennsylvania 15261, USA
    Arthritis Rheum 52:2607-15. 2005
  40. ncbi request reprint Normal scores for nine maneuvers of the Childhood Myositis Assessment Scale
    Robert M Rennebohm
    Division of Pediatric Rheumatolgy, Columbus Children s Hospital and The Ohio State University, 43205, USA
    Arthritis Rheum 51:365-70. 2004
    ..To document and evaluate the scores that normal, healthy children achieve when performing 9 maneuvers of the Childhood Myositis Assessment Scale (CMAS)...
  41. doi request reprint Juvenile dermatomyositis and other idiopathic inflammatory myopathies of childhood
    Brian M Feldman
    Departments of Pediatrics, Health Policy Management and Evaluation, and Public Health Sciences, University of Toronto, Division of Rheumatology, Hospital for Sick Children, Toronto, ON, Canada
    Lancet 371:2201-12. 2008
    ..Disease outcome, if treatment is initiated early, is generally good. Randomised controlled trials are needed to define the most effective treatments...
  42. doi request reprint Applicability of the paediatric rheumatology international trials organisation disease activity core set for juvenile dermatomyositis: comment on the article by Ruperto et al
    Lisa G Rider
    Arthritis Rheum 59:1197-8; author reply 1198-9. 2008
  43. ncbi request reprint Diagnostic criteria for polymyositis and dermatomyositis
    Frederick W Miller
    Lancet 362:1762-3; author reply 1763. 2003
  44. ncbi request reprint A novel autoantibody to a 155-kd protein is associated with dermatomyositis
    Ira N Targoff
    Veterans Affairs Medical Center
    Arthritis Rheum 54:3682-9. 2006
    ..This study was undertaken as part of a larger effort to define novel autoantibodies that assist in the clinical evaluation of myositis...